Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

This study is ongoing, but not recruiting participants.

Study NCT00478465 Information provided by Stanford University

First Received: May 23, 2007 Last Updated: August 29, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2007
Estimated Primary Completion Date:	No date given